BioCardia (BCDA) director granted 8,000 stock options at $1.20
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BioCardia, Inc. director Jim L. Allen received a grant of 8,000 stock options to buy common stock at an exercise price of $1.20 per share. These options vest and become exercisable in full on the one-year anniversary of the grant date, if he continues as a service provider through that date.
After this award, he holds 23,313 stock options in total. This is a compensation-related grant rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Allen Jim L.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 8,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 23,313 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 8,000 options
Exercise price: $1.20 per share
Total options after grant: 23,313 options
+2 more
5 metrics
Options granted
8,000 options
Stock Option (right to buy) grant on July 6, 2026
Exercise price
$1.20 per share
Exercise price for newly granted options
Total options after grant
23,313 options
Total derivative holdings following transaction
Expiration date
July 6, 2036
Option expiration for this grant
Transaction code
A (Grant, award, or other acquisition)
Indicates compensation-related acquisition, not open-market trade
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 1.2000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares are subject to the option vesting and becoming exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-07-06T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did BioCardia (BCDA) director Jim L. Allen report?
Jim L. Allen reported receiving 8,000 stock options as a grant. The options give him the right to buy BioCardia common stock at a fixed exercise price as part of his director compensation package, rather than reflecting an open-market trade.
What is the exercise price of Jim L. Allen’s new BioCardia (BCDA) stock options?
The newly granted 8,000 stock options have an exercise price of $1.20 per share. This means Allen can purchase BioCardia common stock at $1.20 once the options vest, regardless of the market price at that future time.
When do Jim L. Allen’s newly granted BioCardia (BCDA) stock options vest?
All 8,000 stock options vest on the one-year anniversary of the grant date. Vesting is conditional on Allen continuing as a service provider to BioCardia through that date, after which the options become exercisable under their standard terms.
When do Jim L. Allen’s BioCardia (BCDA) stock options expire?
The newly granted options expire on July 6, 2036. After that date, any unexercised options become worthless, so Allen must exercise vested options before expiration if he chooses to purchase BioCardia common shares at the set price.
How many BioCardia (BCDA) stock options does Jim L. Allen hold after this grant?
Following the 8,000-option grant, Allen holds 23,313 stock options in total. This figure reflects his derivative position in BioCardia equity from options only, as reported in this Form 4, and does not describe any separate common share holdings.